We are live on ! Find out more
AI

Accredited Investors Portfolio holdings

AUM $2.31B
1-Year Est. Return 33.7%
This Fund
S&P 500
This Quarter Est. Return
+17.42%
1 Year Est. Return
+33.7%
3 Year Est. Return
+74.04%
5 Year Est. Return
+69.22%
10 Year Est. Return
+269.29%
AUM
$597M
AUM Growth
+$120M
Cap. Flow
+$37.5M
Cap. Flow %
6.27%
Top 10 Hldgs %
63.19%
Holding
161
New
24
Increased
59
Reduced
49
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 8.69%
2 Industrials 7.02%
3 Healthcare 2.89%
4 Consumer Staples 2.59%
5 Financials 2.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
76
Bank of America
BAC
$442B
$692K 0.12%
22,833
+965
+4% +$25.9K
PFE icon
77
Pfizer
PFE
$153B
$691K 0.12%
18,771
-1,190
-6% -$43.6K
VZ icon
78
Verizon
VZ
$196B
$684K 0.11%
11,641
+194
+2% +$11.5K
USXF icon
79
iShares ESG Advanced MSCI USA ETF
USXF
$1.51B
$665K 0.11%
21,234
+1,058
+5% +$31.4K
BR icon
80
Broadridge
BR
$19B
$658K 0.11%
4,295
ABBV icon
81
AbbVie
ABBV
$435B
$646K 0.11%
6,026
+37
+0.6% +$3.56K
HRL icon
82
Hormel Foods
HRL
$13.8B
$613K 0.1%
13,142
+118
+0.9% +$5.76K
KO icon
83
Coca-Cola
KO
$375B
$599K 0.1%
10,918
+835
+8% +$43.2K
IBM icon
84
IBM
IBM
$224B
$598K 0.1%
4,971
-204
-4% -$23.6K
CSCO icon
85
Cisco
CSCO
$479B
$589K 0.1%
13,157
+1,458
+12% +$59.9K
DXCM icon
86
DexCom
DXCM
$32B
$586K 0.1%
6,340
RVNC
87
DELISTED
Revance Therapeutics, Inc.
RVNC
$581K 0.1%
+20,491
New +$531K
LLY icon
88
Eli Lilly
LLY
$1.06T
$537K 0.09%
3,180
+146
+5% +$21.8K
EFA icon
89
iShares MSCI EAFE ETF
EFA
$80.2B
$534K 0.09%
7,316
+251
+4% +$17.2K
CVX icon
90
Chevron
CVX
$366B
$526K 0.09%
6,233
+1,341
+27% +$109K
ZTS icon
91
Zoetis
ZTS
$30B
$495K 0.08%
2,992
-45
-1% -$7.32K
COST icon
92
Costco
COST
$420B
$481K 0.08%
1,277
-32
-2% -$12K
PM icon
93
Philip Morris
PM
$295B
$472K 0.08%
5,701
-27
-0.5% -$2.1K
AXP icon
94
American Express
AXP
$230B
$470K 0.08%
3,888
+115
+3% +$12.7K
HON icon
95
Honeywell
HON
$78B
$440K 0.07%
2,192
-1,170
-35% -$213K
BA icon
96
Boeing
BA
$185B
$423K 0.07%
1,974
+202
+11% +$38.8K
IWS icon
97
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$418K 0.07%
4,311
-1,443
-25% -$130K
ELV icon
98
Elevance Health
ELV
$85.5B
$417K 0.07%
1,300
BDX icon
99
Becton Dickinson
BDX
$48.2B
$415K 0.07%
1,702
NVDA icon
100
NVIDIA
NVDA
$5.42T
$414K 0.07%
31,680
+12,600
+66% +$169K

Similar funds

Accredited Investors's Q4 2020 Portfolio in Review

As of Q4 2020, Accredited Investors held 161 positions worth $597M, up 25% from $477M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Accredited Investors deployed $37.5M of net new capital in Q4 2020, opening 24 new positions and adding to 59 existing holdings. Its largest new stake was Fastenal: 41,306 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 9.2% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $2.46M trimmed.

  • Accredited Investors's largest Q4 2020 buy was Fastenal: 41,306 shares worth $1.01M.
  • Accredited Investors added most to iShares MSCI All Country Asia ex Japan ETF in Q4 2020, an estimated $16.5M increase.
  • Accredited Investors's biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $2.46M.
  • Accredited Investors fully exited Salesforce in Q4 2020, selling an estimated $211K.
  • Accredited Investors's ten largest holdings make up 63% of its $597M portfolio in Q4 2020.
  • Accredited Investors opened 24 new positions and closed 5 in Q4 2020.
  • Accredited Investors's portfolio value rose 25% quarter-over-quarter to $597M.

Based on Accredited Investors's 13F filing for Q4 2020, filed 11 Feb 2021.